Pre-made Altumomab benchmark antibody (Radiolabelled antibody, anti-CEACAM5/CD66e therapeutic antibody, Anti-CEA Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-INN-730

Pre-made Altumomab benchmark antibody (Radiolabelled antibody, anti-CEACAM5/CD66e therapeutic antibody, Anti-CEA Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Indium (111In) altumomab pentetate (INN) (USP, indium In 111 altumomab pentetate; trade name Hybri-ceaker) is a mouse monoclonal antibody linked to pentetate which acts as a chelating agent for the radioisotope indium-111. The drug is used for the diagnosis of colorectal cancer.[1][2]

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-INN-730-1mg 1mg 3090
GMP-Bios-INN-730-10mg 10mg Inquiry
GMP-Bios-INN-730-100mg 100mg Inquiry
GMP-Bios-INN-730-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Altumomab Biosimilar, Radiolabelled Antibody, Anti-CEACAM5/CD66e Antibody: Anti-CEA therapeutic antibody
INN Name Altumomab
TargetCEACAM5/CD66e
FormatRadiolabelled antibody
DerivationMus musculus
Species Reactivityhuman
CH1 IsotypeIgG1 - nd
VD LCIgG1 - nd
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
CompaniesEli Lilly (Indianapolis IN USA) / Hybritech Inc. (San Diego CA USA)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech0